These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Delayed Diagnosis of Graves' Thyrotoxicoisis Presenting as Recurrent Adrenal Crisis in Primary Adrenal Insufficiency. Naik D; Jebasingh KF; Thomas N J Clin Diagn Res; 2016 Apr; 10(4):OD20-2. PubMed ID: 27190873 [TBL] [Abstract][Full Text] [Related]
67. Octreotide and Graves' ophthalmopathy. Perros P; James RA; Kendall-Taylor P BMJ; 1992 Feb; 304(6825):507. PubMed ID: 1547436 [No Abstract] [Full Text] [Related]
68. The influence of uremia on pharmacokinetics and protein binding of prednisolone. Bergrem H Acta Med Scand; 1983; 213(5):333-7. PubMed ID: 6880855 [TBL] [Abstract][Full Text] [Related]
69. Therapy of Graves' ophthalmopathy: a novel application of somatostatin analogues. Díez JJ Expert Opin Pharmacother; 2001 Sep; 2(9):1361-5. PubMed ID: 11585016 [No Abstract] [Full Text] [Related]
70. [Paradoxical embolism in a case with Graves' ophthalmopathy during steroid therapy]. Yonekura T; Ago T; Sato K; Okamura K; Fukuda K; Abe I; Iida M Nihon Naika Gakkai Zasshi; 2002 Aug; 91(8):2479-80. PubMed ID: 12373862 [No Abstract] [Full Text] [Related]
71. Pharmacokinetics of prednisolone in children with nephrosis. Miller PF; Bowmer CJ; Wheeldon J; Brocklebank JT Arch Dis Child; 1990 Feb; 65(2):196-200. PubMed ID: 2317067 [TBL] [Abstract][Full Text] [Related]
72. Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients. Bergrem H; Jervell J; Flatmark A Kidney Int; 1985 Feb; 27(2):459-64. PubMed ID: 3887001 [TBL] [Abstract][Full Text] [Related]
73. Graves' disease and thyroxine-binding globulin excess. Li Calzi L; Benvenga S Arch Intern Med; 1989 Mar; 149(3):705. PubMed ID: 2493231 [No Abstract] [Full Text] [Related]
74. Decreased clearance of prednisolone, a factor in the development of corticosteroid side effects. Kozower M; Veatch L; Kaplan MM J Clin Endocrinol Metab; 1974 Mar; 38(3):407-12. PubMed ID: 4815171 [No Abstract] [Full Text] [Related]
76. Urinary and plasma glycosaminoglycans in endocrine ophthalmopathy. Schuler M; Hansen C; Winand R; Stover C; Otto E; Beyer J; Kahaly G Dev Ophthalmol; 1993; 25():58-67. PubMed ID: 8359354 [No Abstract] [Full Text] [Related]
77. Ophthalmic manifestations of endocrine disorders-endocrinology and the eye. Kamboj A; Lause M; Kumar P Transl Pediatr; 2017 Oct; 6(4):286-299. PubMed ID: 29184810 [TBL] [Abstract][Full Text] [Related]
78. Cyclosporin A in management of Graves' disease. McGregor AM; Beck L; Hall R J R Soc Med; 1985 Jun; 78(6):511-2. PubMed ID: 3839019 [No Abstract] [Full Text] [Related]
79. Endocrine ophthalmopathy. Ramsay ID Br Med J; 1968 Dec; 4(5632):706. PubMed ID: 4301983 [No Abstract] [Full Text] [Related]
80. Prednisolone pharmacokinetics compared between night and day in asthmatic and normal subjects. McAllister WA; Mitchell DM; Collins JV Br J Clin Pharmacol; 1981 Mar; 11(3):303-4. PubMed ID: 7194101 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]